Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus

  title={Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus},
  author={J. Doucet and A. Chacra and Pierre Maheux and J. Lu and Susan Harris and J. Rosenstock},
  journal={Current Medical Research and Opinion},
  pages={863 - 869}
  • J. Doucet, A. Chacra, +3 authors J. Rosenstock
  • Published 2011
  • Medicine
  • Current Medical Research and Opinion
  • Abstract Objective: To assess the safety and efficacy of saxagliptin (5 mg once-daily) in older patients (≥65 years of age) with inadequately controlled type 2 diabetes. Research design and methods: In this retrospective subgroup analysis, data from five randomized, double-blind, placebo-controlled, multicenter, 24-week, phase 3 trials were included. The primary studies evaluated saxagliptin 5 mg once-daily (monotherapy or add-on) in patients aged 18–77 years with HbA1c ≥7.0% (four studies) or… CONTINUE READING
    58 Citations
    Saxagliptin efficacy and safety in patients with type 2 diabetes receiving concomitant statin therapy.
    • 2
    Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes
    • 19
    • PDF


    Management of Type 2 Diabetes in Treatment-Naive Elderly Patients
    • 86
    • PDF
    Risk factors and management of diabetes in elderly French patients.
    • 22
    • PDF
    Management of Type 2 Diabetes Mellitus in the Elderly
    • 89
    Use of antidiabetic drugs in elderly patients.
    • 29
    • PDF